Identification of a RING protein that can interact in vivo with the BRCA1 gene product

LC Wu, ZW Wang, JT Tsan, MA Spillman, A Phung… - Nature …, 1996 - nature.com
LC Wu, ZW Wang, JT Tsan, MA Spillman, A Phung, XL Xu, MCW Yang, LY Hwang…
Nature genetics, 1996nature.com
The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that
contains the cysteine–rich RING motif, a zinc–binding domain found in a variety of regulatory
proteins. Here we describe a novel protein that interacts in vivo with the N–terminal region of
BRCA1. This BRCA1–associated RING domain (BARD1) protein contains an N–terminal
RING motif, three tandem ankyrin repeats, and a C–terminal sequence with significant
homology to the phylogenetically conserved BRCT domains that lie near the C terminus of …
Abstract
The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine–rich RING motif, a zinc–binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N–terminal region of BRCA1. This BRCA1–associated RING domain (BARD1) protein contains an N–terminal RING motif, three tandem ankyrin repeats, and a C–terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.
nature.com